207940 — Samsung Biologics Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩55tn
- KR₩55tn
- KR₩4tn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 701,592 | 1,164,777 | 1,568,007 | 3,001,295 | 3,694,589 |
Cost of Revenue | |||||
Gross Profit | 192,007 | 416,076 | 726,451 | 1,468,448 | 1,802,765 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 610,209 | 873,343 | 1,030,697 | 1,952,562 | 2,575,750 |
Operating Profit | 91,383 | 291,434 | 537,310 | 1,048,733 | 1,118,839 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 155,435 | 265,992 | 561,283 | 1,009,025 | 1,119,987 |
Provision for Income Taxes | |||||
Net Income After Taxes | 202,904 | 240,975 | 393,589 | 798,056 | 857,691 |
Net Income Before Extraordinary Items | |||||
Net Income | 202,904 | 240,975 | 393,589 | 798,056 | 857,691 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 202,904 | 240,975 | 393,589 | 798,056 | 857,691 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3,042 | 3,643 | 5,957 | 10,724 | 12,037 |
Dividends per Share |